FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The Food and Drug Administration is rolling out an aggressive plan to make generative AI a linchpin in its decision-making, ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...

The FDA is gathering up AI talent. The Food and Drug Administration is bringing on new artificial intelligence talent and ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.

Supposedly, the AI tool will speed up the FDA's drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI's track record of ...

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...